- Prostate Cancer is the only disease we treat
- We provide balanced advice about the advantages and disadvantages of the entire spectrum of treatment alternatives
- We do not follow the one-size-fits all approach that funnels everyone into the same treatment protocol
- Focusing on quality of life is what makes us unique
|
|
|
 |
Apr 29, 2009 - Cougar Biotechnology Initiates Phase III Trial of CB7630 (Abiraterone Acetate) in Chemotherapy-Naïve Castration-Resistant Prostate Cancer Patients
May 01, 2009 - Abiraterone COU-AA-302 study
Contact our office for more information about enrollment.May 02, 2009 - Sign up to Google Groups: Prostate Oncology SpecialistsMay 02, 2009 - Preview videos--set to release late May 2006 on DVDOct 10, 2009 - Interview with Dr. Scholz
Dec 15, 2009 - MDV3100 Castration-Resistant Prostate Cancer. Sponsor: Medivation, Inc.
Jan 07, 2010 - Debuting in August 2010 by Ralph Blum and Mark Scholz, MD. Pre-orders available at Amazon, Borders, Barnes and Noble and Random House
|
 |
|